[{"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) may be potentially mislabeled as     RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedigree: AD54549_16, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) has the following code    Pedigree: AD54553_1, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904759160", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-490-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["S2"], "generic_name": ["RACEPINEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["Nephron SC, Inc."], "product_ndc": ["0487-5901"], "product_type": ["HUMAN OTC DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["RACEPINEPHRINE HYDROCHLORIDE"], "rxcui": ["310133", "863968"], "spl_id": ["29a1c681-84ee-71a8-e063-6394a90ad7e5"], "spl_set_id": ["dd1b35c7-b23b-4b95-8162-df3d263fe32e"], "package_ndc": ["0487-5901-99"], "is_original_packager": [true], "upc": ["0304875901999", "304875901999"], "unii": ["336096P2WE"]}, "product_type": "Drugs", "event_id": "91451", "recalling_firm": "Nephron Sc Inc", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States including Puerto Rico. Guatamala", "recall_number": "D-0176-2023", "product_description": "S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9", "product_quantity": "925,920 vials", "reason_for_recall": "Short Fill", "recall_initiation_date": "20230113", "center_classification_date": "20230123", "termination_date": "20241011", "report_date": "20230201", "code_info": "Lot #: 126461, 126431 Exp. 04/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Scott", "state": "LA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78669", "recalling_firm": "Intrathecal Compounding Specialist, LLC", "address_1": "206 Jacobs Run", "address_2": "N/A", "postal_code": "70583-8907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0320-2018", "product_description": "All sterile drug preparations remaining within expiry prepared from Fentanyl Citrate  Base Solution dispensed between October 16, 2017 and November 17, 2017 Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.", "product_quantity": "Unknown.", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171130", "center_classification_date": "20180204", "termination_date": "20190501", "report_date": "20180214", "code_info": "All lots remaining within expiry (BUDs between November 15, 2017 and December 16, 2017)"}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86799", "recalling_firm": "Advanced Nutriceuticals, LLC", "address_1": "836 E 86th St", "address_2": "N/A", "postal_code": "46240-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, CO, FL, IN, KY, OH, TX", "recall_number": "D-0138-2021", "product_description": "DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20201130", "center_classification_date": "20201211", "report_date": "20201223", "code_info": "Lot #1111202002, Exp 12/11/2020"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1200-2019", "product_description": "Prostaglandin Tri-Mix 5:15:0.5 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1140-2019", "product_description": "Vancomycin 125 mg/3mL Inhalation, 3 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0551-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-03", "product_quantity": "2,551 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: X024051, Exp 04/25/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0983-2023", "product_description": "oxyTOCIN, 20 units added to dextrose 5%/lactated ringers 1000 mL, IV Bag, Rx Only, This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6031-1", "product_quantity": "463 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-249711, Exp. 8/20/2023; 36-250340, Exp. 8/23/2023; 36-251645, Exp. 8/27/2023"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1771-2019", "product_description": "Doxorubicin Liposomal 71 MG / 250 ML D5W IVPB; Doxorubicin Liposomal 66 MG/250 ML D5W, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233     Doxorubicin 16 MG/1000 ML NS IV WITH Vincristine 0.6 MG and Etoposide 78 MG  Doxorubicin 16 MG/1000 ML NS IV WITH Vincristine 0.6 MG and Etoposide 78 MG   Duplicate  Doxorubicin 45 MG / 22.5 ML IVP SYRINGE", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "8 ml", "code_info": "All lots distributed between November 2014 and May 2015;  12302014@48, 6/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (30/0.5/10) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1775-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1021-2017", "product_description": "NORepinephrine Bitartrate 8 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0774-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170502@31 BUD: 7/16/2017; 20170508@34 BUD: 7/22/2017; 20170508@70 BUD: 7/22/2017; 20170512@15 BUD: 7/26/2017"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0984-2016", "product_description": "ESTRADIOL VALERATE 40MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 02162016:85@45, Exp. 5/17/2016; Lot #:03092016:30@19, Exp. 06/07/2016; Lot #: 01282016:77@25, Exp.05/03/2016; Lot #: 3112016:98@21, Exp. 06/13/2016; Lot #:03242016:52@22, Exp. 06/27/2016; Lot #: 04122016:15@50, Exp. 7/11/2016"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-655-2015", "product_description": "Estradiol Cypionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "3925 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94900", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0601-2024", "product_description": "Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.", "product_quantity": "116,144 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.", "recall_initiation_date": "20240628", "center_classification_date": "20240716", "report_date": "20240724", "code_info": "Lot #s: CNSDH, Exp. 6/30/2024; CNWVM, CNWWH, Exp. 07/31/2024; CNXKW, CNXKY, CNXMB, CNXMH, Exp. 09/30/2024; CPBTP, CPBTV, Exp. 11/30/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075350"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["45963-555", "45963-556", "45963-557"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["6aac08f8-9632-478d-86ae-b2f6927064f0"], "spl_set_id": ["5969871e-6c71-4c37-9d63-370718ccc80c"], "package_ndc": ["45963-555-11", "45963-555-50", "45963-556-11", "45963-556-50", "45963-557-11", "45963-557-50"], "is_original_packager": [true], "upc": ["0345963555113", "0345963556110"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "70001", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0338-2015", "product_description": "Gabapentin Capsules, USP, 100 mg, Rx Only, a) 100 capsules per bottle, NDC 45963-555-11, b) 500 Capsules per bottle, NDC 45963-555-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA.", "product_quantity": "29,622 Bottles", "reason_for_recall": "Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.", "recall_initiation_date": "20141215", "center_classification_date": "20150108", "termination_date": "20151120", "report_date": "20150114", "code_info": "Lot #s: a) G01966A1, Exp 10/2015, b) G02004A1, Exp 03/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Chatham", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71591", "recalling_firm": "Liberty Drug & Surgical", "address_1": "195 Main St", "address_2": "N/A", "postal_code": "07928-2405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY", "recall_number": "D-1397-2015", "product_description": "Glycerin (v/v) 72% Injection, 25 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ  07928.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.", "recall_initiation_date": "20150615", "center_classification_date": "20150827", "termination_date": "20180423", "report_date": "20150902", "code_info": "Lot #: 05122015@6, Exp 06/26/15"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1527-2020", "product_description": "Phentermine HCL Yellow Caps 30mg, packaged in 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: Tagi Pharma, South Beloit, IL 61080; NDC 51224-0202-70", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #:19212; Exp. Date: 10/20"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Wilson's Nasal Irrigation Solution, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0470-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0286-2023", "product_description": "DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML syringe(c)  630MG IN NS 31.5ML used with a home pump; antibiotic, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "17 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-30, 2022"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-980-2013", "product_description": "MIC-CARN + B6/B12/LIDOCAINE 25/50/50/175MCG/1/0.1MG/ML INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "02142013@6, 05022013@15, 07192013@13", "more_code_info": ""}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-462-2013", "product_description": "Trimix Inj 30:1:20 MDV: 5 ml, 10 ml, 2x5 ml  Penile Injection, 30 and 90 day expiration,", "product_quantity": "72", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204203"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6801", "0904-6802", "0904-6803", "0904-6804", "0904-6805"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "spl_id": ["cdab9d60-c12c-474b-aa71-b7916dab8e7c"], "spl_set_id": ["b02324b1-e7f0-4cbc-8778-5f7c4a5d194a"], "package_ndc": ["0904-6801-61", "0904-6802-61", "0904-6803-61", "0904-6804-61", "0904-6805-61"], "original_packager_product_ndc": ["68180-612", "68180-613", "68180-614", "68180-615", "68180-616"], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "85138", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0999-2020", "product_description": "Quetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA.  NDC: 0904-6801-61", "product_quantity": "330 cartons", "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.", "recall_initiation_date": "20200227", "center_classification_date": "20200311", "termination_date": "20220924", "report_date": "20200318", "code_info": "Lot, expiry: Lot N00028, exp 04/2021; Lot N00044, exp 06/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0522-2019", "product_description": "Dr. King's Lymph Detox, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955506324, NDC 57955-5063-2", "product_quantity": "6446 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 081815F Exp. 08/18; 030916V Exp. 03/19; 061316B Exp. 06/19; 1208016H Exp. 12/19; 010118BE Exp. 01/01/20; 041017M Exp. 04/19"}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "address_2": "", "product_quantity": "247 bottles", "code_info": "Lot K022616D", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Healthful Naturals DizziFree Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-204-02", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0255-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Lilburn", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94893", "recalling_firm": "Guru Inc.", "address_1": "4370 Lawrenceville Hwy NW", "address_2": "# 2204", "postal_code": "30047-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Retail: South Carolina, North Carolina, Ohio;  Consumer level: Nationwide within USA", "recall_number": "D-0666-2024", "product_description": "Infla-650 Herbal Dietary Supplement, 700mg,  packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box 2204, Lilburn, GA 30047-1100, USA. Ph.: 872 216 1566, http://www.dalayurevda.com, Made in India, UPC: 042535355019", "product_quantity": "", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.", "recall_initiation_date": "20240626", "center_classification_date": "20240923", "report_date": "20241002", "code_info": "Batch # IN-032, Exp 11/30/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020047"], "brand_name": ["DEXTROSE"], "generic_name": ["DEXTROSE MONOHYDRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0719"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXTROSE MONOHYDRATE"], "rxcui": ["237656"], "spl_id": ["aa64f648-e931-4a99-9b81-791a3827272c"], "spl_set_id": ["0332f34a-7038-47cc-ba59-d55cad6b73ca"], "package_ndc": ["0338-0719-06"], "is_original_packager": [true], "unii": ["LX22YL083G"]}, "product_type": "Drugs", "event_id": "72816", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0958-2016", "product_description": "Dextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bulk Package, Not For Direct Infusion, Must Be Diluted, Rx Only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0719-06", "product_quantity": "28,080 VIAFLEX Plastic Containers", "reason_for_recall": "Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.", "recall_initiation_date": "20151215", "center_classification_date": "20160606", "termination_date": "20220415", "report_date": "20160615", "code_info": "Lot # C985150; Exp.  07/16"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1022-2017", "product_description": "NORepinephrine Bitartrate 16 mg in 0.9% Sodium Chloride 250 mL from Stock, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0775-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170512@8 BUD: 8/10/2017; 20170506@18 BUD: 8/4/2017"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206434"], "brand_name": ["ROSUVASTATIN"], "generic_name": ["ROSUVASTATIN"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-284", "16729-285", "16729-286", "16729-287"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROSUVASTATIN CALCIUM"], "rxcui": ["859419", "859424", "859747", "859751"], "spl_id": ["236bf0a1-88be-0b80-e063-6394a90a283f"], "spl_set_id": ["3ffe0294-3997-2755-e054-00144ff8d46c"], "package_ndc": ["16729-284-10", "16729-284-15", "16729-284-17", "16729-285-10", "16729-285-15", "16729-285-17", "16729-286-10", "16729-286-15", "16729-286-17", "16729-287-10", "16729-287-15", "16729-287-17"], "is_original_packager": [true], "unii": ["83MVU38M7Q"], "upc": ["316729287104", "316729287159", "316729287173"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0407-2023", "product_description": "Rosuvastatin Tablets, USP 40 mg* Rx Only, Packaged as: a) 30-count bottle NDC 16729-287-10, UPC 3 16729 28710 4; b) 90-count bottle NDC 16729-287-15, UPC 3 16729 28715 9; c) 1,000-count bottle NDC 16729-287-17, UPC 3 16729 28717 3; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA", "product_quantity": "102,360 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2100343, Exp. Date 12/31/2023; P2102371, Exp. Date 3/31/2024;  b) P2101966, Exp. Date 2/28/2024; P2104545, Exp. Date 6/30/2024; P2204500, Exp. Date 7/31/2025; P2205415, Exp. Date 8/31/2025;  c) P2101591, Exp. Date 2/28/2023; P2200062, Exp. Date 12/31/2024; P2204336, Exp. Date 7/31/2025; P2204337, Exp. Date 7/31/2025; P2205416, Exp. Date 8/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0091-2021", "product_description": "MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles, MD Professional LLC, Minneapolis, MN", "product_quantity": "2,655 bottles", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: DX278, Exp. Date Apr-23"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; METAXALONE Tablet, 800 mg may be potentially mislabeled as    ESTERIFIED ESTROGENS, Tablet, 0.625 mg, NDC 61570007301, Pedigree: W003736, EXP: 6/26/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "METAXALONE Tablet, 800 mg has the following code    Pedigree: W003738, EXP: 6/26/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METAXALONE Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64720032110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-694-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67080", "recalling_firm": "Zions RX Formulations Services LLC dba RX Formuations Serv.", "address_1": "5949 E University Dr", "address_2": "N/A", "postal_code": "85205-7435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "AZ", "recall_number": "D-1216-2014", "product_description": "Oxytocin 30 Units in 500mL Sodium Chloride 0.9% Bags, Not for Dispensing, For Hospital Administration Only, Rx Formulations, 5949 East University Drive, Mesa, AZ 85205", "product_quantity": "1,495 Bags", "reason_for_recall": "Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.", "recall_initiation_date": "20131212", "center_classification_date": "20140407", "termination_date": "20140501", "report_date": "20140416", "code_info": "Lot #: 117440@1 Expiration Date: 12/27/2013   Lot #: 117901@2 Expiration Date: 01/03/2014   Lot #: 118291@32 Expiration Date: 01/05/2014   Lot #: 118392@28 Expiration Date: 01/09/2014   Lot #: 117659@66 Expiration Date: 12/26/2013   Lot #: 118348@17 Expiration Date: 01/09/2014   Lot #: 117601@38 Expiration Date: 12/26/2013   Lot #: 117847@13 Expiration Date: 12/29/2013   Lot #: 118058@47 Expiration Date: 01/02/2014"}, {"status": "Terminated", "city": "Huntington", "state": "IN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76177", "recalling_firm": "Ecolab, Inc.", "address_1": "970 E Tipton St", "address_2": "N/A", "postal_code": "46750-1611", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States, Puerto Rico and Canada", "recall_number": "D-0454-2017", "product_description": "Endure 400 Scrub-Stat (chlorhexidine gluconate) Foam Forming Solution, 4%, packaged in plastic (HDPE) bottles, Over-the-counter,  Model Number: 61430436 (800 mL, 12 bottles/case)  - United States; Model Number: 6000179 (800 mL, 12 bottles/case) - Canada, Ecolab, St. Paul, MN 55102, NDC 47593-265-36", "product_quantity": "427 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20161202", "center_classification_date": "20170131", "termination_date": "20170906", "report_date": "20170208", "code_info": "Lot # L050261, Exp 05/18", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78118", "recalling_firm": "Amerisource Health Services", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0074-2018", "product_description": "Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only.  Packaged and Distributed by:  American Health Packaging, Columbus, Ohio 43217.  NDC:  68084-390-01", "product_quantity": "93,600 tablets", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20170829", "center_classification_date": "20171110", "termination_date": "20190821", "report_date": "20171122", "code_info": "Lot #:167194; Exp. 12/31/2018"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["MURO 128"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Bausch & Lomb Incorporated"], "product_ndc": ["24208-385"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1298435", "1299626"], "spl_id": ["22f5a4ba-407c-faf9-e063-6394a90a17a5"], "spl_set_id": ["93fafa27-5031-4d95-b4b8-5574b7204ae2"], "package_ndc": ["24208-385-55", "24208-385-56", "24208-385-01"], "is_original_packager": [true], "upc": ["0324208385562", "324208385012", "324208385555"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "68348", "recalling_firm": "Bausch & Lomb, Inc.", "address_1": "8500 Hidden River Pkwy", "address_2": "N/A", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Canada, and Hong Kong.", "recall_number": "D-1410-2014", "product_description": "Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tube per carton, professional sample, NDC 24208-385-01, UPC 3 24208-385-01 2; b) 1/8 oz. (3.5 g) tube per carton, NDC 24208-385-55, UPC 3 24208-385-55 5; and c) 1/4 oz. (7 g) Twin Pack, Two 1/8 oz. (3.5 g) tubes per carton, NDC 24208-385-56, UPC 3 24208-385-56 3; Bausch & Lomb Incorporated, Tampa, FL  33637.", "product_quantity": "a) 4,165 tubes; b) and c) 844,879 tubes", "reason_for_recall": "Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.", "recall_initiation_date": "20140410", "center_classification_date": "20140625", "termination_date": "20170414", "report_date": "20140702", "code_info": "Lot #: a) 179271, Exp 08/14; b) and c) 146791, 146932, Exp 06/14; 151221, 151922, Exp 09/14; 159102, Exp 02/15; 160912, Exp 03/15; 162422, Exp 04/15; 163641, 05/15; 166592, Exp 07/15; 169273, Exp 09/15; 170482, Exp 10/15; 174882, Exp 12/15; 176932, Exp 01/16; 179272, Exp 02/16; 182772, Exp 05/16; 186722, Exp 07/16; 190182, Exp 09/16; and 191631, Exp 10/16"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1139-2020", "product_description": "Immune-2100, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "40 pumps", "code_info": "Lot # 5/14/18 0749 525-66102, BUD 6/13/2018; 5/22/18 0837 495-66102, BUD 6/21/2018", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "0.2% ROPivacaine - OnQ Pump, (ROPivacaine HCL (USP) 1100mg, 0.9% Sodium Chloride (USP) QS 550 ml, single dose pump. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77056. NDC: 42852-661-02", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0928-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0083-2021", "product_description": "DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486509627", "product_quantity": "4,878 tubes", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot # FW937, Exp. Date Jun-22"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1390-2022", "product_description": "READY IN CASE RUBBING ALCHL 50 PCT WNTRGRN 16 FLOZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU:900535", "more_code_info": ""}, {"status": "Terminated", "city": "Salem", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83538", "recalling_firm": "Ridge Properties, LLC", "address_1": "4995 Ridge Dr NE", "address_2": "N/A", "postal_code": "97301-7475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA via internet sales through Amazon.com; ebay.com; Walmart.com; tatbalm.net; Naturallyhl.com", "recall_number": "D-1861-2019", "product_description": "Soothing Sore Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-077-14), b)  2 Oz (NDC 69804-077-15), and c) 4 Oz (NDC 69804-077-16) bottles, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.", "product_quantity": "104.1 ounces", "reason_for_recall": "Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.", "recall_initiation_date": "20190809", "center_classification_date": "20190913", "termination_date": "20230712", "report_date": "20190925", "code_info": "Lot # 1135, Exp 12/27/2022"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0053-2023", "product_description": "SEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "800.5 mL in unit dose vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65680, BUD: 10/11/2022; 66043, BUD: 10/15/2022; 66372, BUD: 10/23/2022; 66597, BUD: 10/29/2022"}, {"status": "Ongoing", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82326", "recalling_firm": "Legacy Pharmaceutical Packaging LLC", "address_1": "13333 Lakefront Dr", "address_2": "N/A", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Wal-Mart distribution centers in AR, CA, GA, IN and MD", "recall_number": "D-1049-2019", "product_description": "Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by:  Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045.  NDC 68645-578-54", "product_quantity": "2,851,284 bottles", "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected", "recall_initiation_date": "20190301", "center_classification_date": "20190321", "report_date": "20190327", "code_info": "Lots: 180921, exp Sep-19,  180922, exp Oct-19, 180923, 180924, 181118, exp Nov-19, 181119, exp Oct-19, 181407, exp Nov-19,  181408, exp Dec-19, 181573, 181725, 181726, exp Feb-20, 181948, exp Mar-20, 181960, exp Feb-20, 182385, 182386, 182387, exp Mar-20"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0205-2015", "product_description": "METHYCOBALAMIN, preservative, 1mg/mL, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "1320 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140715@2, discard date: 10/13/2014;  Lot #: 20140724@10, discard date: 10/22/2014;  Lot #: 20140812@14, discard date: 11/1/2014;  Lot #: 20140826@5, discard date: 11/1/2014;"}, {"status": "Terminated", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75164", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS", "recall_number": "D-1546-2016", "product_description": "Olopatadine 0.8% Ophthalmic Solution, 3ml bottle, Rx, Vital Care Compounder, Hattiesburg, MS", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160726", "center_classification_date": "20160927", "termination_date": "20161118", "report_date": "20161005", "code_info": "Lot# 389278, Use by 8-9-16"}, {"status": "Terminated", "city": "Brentwood", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89563", "recalling_firm": "Celebrate Today", "address_1": "143 Front Ave", "address_2": "N/A", "postal_code": "11717-5113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide in the USA via Amazon Marketplace", "recall_number": "D-0638-2022", "product_description": "RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.", "product_quantity": "500 cartons", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20220208", "center_classification_date": "20220228", "termination_date": "20220329", "report_date": "20220223", "code_info": "Lot # DK1027, Exp. 08/01/2023"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69445", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0052-2015", "product_description": "APLENZIN\u00bf (bupropion hydrobromide), extended-release tablets, 348 mg, a) 7-count HDPE bottle (NDC 0024-5811-07), b) 30-count HDPE bottle (NDC 0024-5811-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7", "product_quantity": "23,057 HDPE bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert", "recall_initiation_date": "20140605", "center_classification_date": "20141028", "termination_date": "20170727", "report_date": "20141105", "code_info": "Lot #: a) 13E020P; Exp. 03/17  Lot #: b) 13E029P, 13E028P, 13K032P; Exp. 03/17", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021947"], "brand_name": ["FENTANYL BUCCAL"], "generic_name": ["FENTANYL CITRATE"], "manufacturer_name": ["Mayne Pharma"], "product_ndc": ["51862-636", "51862-634", "51862-635", "51862-637", "51862-638"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["BUCCAL", "SUBLINGUAL"], "substance_name": ["FENTANYL CITRATE"], "rxcui": ["668363", "668364", "668365", "668366", "668367"], "spl_id": ["0ad275cd-db4f-434c-9675-2c7f9655366c"], "spl_set_id": ["918d0e2a-3af3-46e8-ad06-528263e03ba0"], "package_ndc": ["51862-634-01", "51862-634-28", "51862-635-01", "51862-635-28", "51862-636-01", "51862-636-28", "51862-637-01", "51862-637-28", "51862-638-01", "51862-638-28"], "is_original_packager": [true], "unii": ["MUN5LYG46H"]}, "product_type": "Drugs", "event_id": "92133", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0767-2023", "product_description": "Fentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-635-28", "product_quantity": "397", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert", "recall_initiation_date": "20230427", "center_classification_date": "20230524", "termination_date": "20240229", "report_date": "20230531", "code_info": "Lot #: 100020528, Exp 09/2024; 100026699, Exp 11/2024"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0751-2020", "product_description": "MORPHINE 10MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "4 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@13 Exp. 12/21/2019; 12172019@9 Exp. 12/26/2019; 12122019@10 Exp. 12/21/2019; 12162019@13 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0594-2020", "product_description": "Morphine Sulfate and Fentanyl Citrate and Baclofen in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M007"], "brand_name": ["CITROMA"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["OLD EAST MAIN CO"], "product_ndc": ["55910-183"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "spl_id": ["372442ed-7b24-3514-e063-6394a90af70e"], "spl_set_id": ["51ed515b-cc51-4ea1-b612-090476135005"], "package_ndc": ["55910-183-38"], "is_original_packager": [true], "unii": ["RHO26O1T9V"], "upc": ["072785134188"]}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1506-2022", "product_description": "Rexall, Magnesium Citrate Saline Laxative, Oral Solution, (1.745 g/fl oz), Lemon Flavor, 10 FL OZ (296 mL), Distributed By Dolgencorp. LLC 100 Mission Ridge, Goodlettsville, TN 37072 or Distributed By Old East Main Co. 100 Mission Ridge Goodlettsville, TN 37072; NDC 55910-183-38, UPC 0 72785 13418 8", "product_quantity": "42,912 bottles", "reason_for_recall": "Microbial contamination of non-sterile products.", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "Lot # 0511629, EXP 12/4/2022; 0562243, EXP 2/17/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "70770", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0425-2015", "product_description": "0.9% Sodium Chloride Injection, USP, 500 mL in VIAFLEX Plastic Container, Rx only, Manufactured by Baxter Healthcare Corp., North Cove, North Carolina Facility Highway 221 North, Marion, NC 28752 for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC 0338-0049-03", "product_quantity": "597,498 units total", "reason_for_recall": "Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.", "recall_initiation_date": "20150318", "center_classification_date": "20150325", "termination_date": "20160224", "report_date": "20150401", "code_info": "Lot #:  C929844, Exp 5/31/2015; C926873, Exp 4/30/2015; C928630, Exp 4/30/2015.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1011-2022", "product_description": "Dihydroergotamine Mesylate, Injection, USP, 1mg/mL, packaged in box of 5 x 1 mL ampules, Rx only, Manufactured for: Perrigo, Minneapolis, MN, NDC 0574-0850-10", "product_quantity": "1 carton", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021269"], "brand_name": ["CARDURA"], "generic_name": ["DOXAZOSIN MESYLATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["58151-078", "58151-079"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXAZOSIN MESYLATE"], "rxcui": ["636360", "636361", "1242404", "1242408"], "spl_id": ["7fe31b0a-4fb2-427f-83e2-d5b957d6738b"], "spl_set_id": ["355bcdce-0481-48ba-8ebd-2009106aaf77"], "package_ndc": ["58151-078-93", "58151-079-93"], "is_original_packager": [true], "upc": ["0358151078936"], "unii": ["86P6PQK0MU"]}, "product_type": "Drugs", "event_id": "96036", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0204-2025", "product_description": "Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93", "product_quantity": "6,605/30 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.", "recall_initiation_date": "20241223", "center_classification_date": "20250116", "termination_date": "20251112", "report_date": "20250122", "code_info": "Lot# 8182298, Exp 10/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040088"], "brand_name": ["METHADONE HYDROCHLORIDE"], "generic_name": ["METHADONE HYDROCHLORIDE"], "manufacturer_name": ["VistaPharm, LLC"], "product_ndc": ["66689-694", "66689-695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHADONE HYDROCHLORIDE"], "rxcui": ["991147"], "spl_id": ["2b71dd6b-0895-4349-ae79-c717c3d863e0"], "spl_set_id": ["d5bd3e97-b3f6-4bc2-9fb7-02921be35cdb"], "package_ndc": ["66689-694-30", "66689-694-79", "66689-694-88", "66689-695-79"], "is_original_packager": [true], "upc": ["0366689695792", "0366689694795"], "unii": ["229809935B"]}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0466-2017", "product_description": "Methadone Hydrochloride Oral Concentrate, USP 10 mg/mL C-II (Sugar Free), 1 liter (1000 mL), 4 bottles per case, Rx only, Manufactured by VistaPharm, Largo, FL 33771, NDC No. 66689-695-79.", "product_quantity": "14,368 bottles", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "Lot No. 423000 (Exp. 10/17), 415100 (Exp. 08/17)", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "12 ml", "code_info": "All lots distributed between November 2014 and May 2015  03252015@48, 9/21/15", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone Bi-Blend 15 mg/ml +Estradiol Valerate 5 mg/ml Injection, Multi-Dose Vial,Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1752-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0040-2018", "product_description": "Oxytocin 20 units added to 1000 mL Lactated Ringer's Injection USP in 1000 mL bag  Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130 Sugar Land, TX 77478, NDC# 71019-241-05.", "product_quantity": "978 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of sterility assurance", "address_2": "", "product_quantity": "20 bags", "code_info": "Lot #: 20170602@29, Exp 7/17/2017", "center_classification_date": "20170713", "distribution_pattern": "LA, PA, NY, WI", "state": "AR", "product_description": "Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL,  Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-32", "report_date": "20170719", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0978-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77600", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20170621", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "", "state": "N/A", "country": "", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67870", "recalling_firm": "Pfizer Inc.", "address_1": "N/A", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide including Puerto Rico and US Virgin Islands. 65 federal government accounts received the affected product directly from Pfizer Inc", "recall_number": "D-1253-2014", "product_description": "Tikosyn\u00bf  (dofetilide) 500 mcg (0.5mg) capsules, 60-count bottle, Rx only Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, NDC 00069-5820-60", "product_quantity": "23,064 bottles", "reason_for_recall": "Presence of Foriegn Tablets/Capsules: A single Tikosyn\u00bf (dofetilide) 250 mcg capsule was discovered in one bottle of Tikosyn\u00bf (dofetilide) 500 mcg (0.5 mg).", "recall_initiation_date": "20140408", "center_classification_date": "20140422", "termination_date": "20170424", "report_date": "20140430", "code_info": "H48496, H48497; Exp 05/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-536-2015", "product_description": "Benazepril active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86508", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States Nationwide", "recall_number": "D-0064-2021", "product_description": "Fluocinonide Ointment USP 0.05%, packaged in: a) 15 gm tube, NDC 52565-0040-15,  b) 30 gm tube, NDC 52565-0040-30 c) 60 gram tube, NDC 52565-0040-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310", "product_quantity": "36,790 tubes", "reason_for_recall": "Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.", "recall_initiation_date": "20200928", "center_classification_date": "20201105", "termination_date": "20220822", "report_date": "20201111", "code_info": "Lot#: a) 12250, Exp 10/2020; 15039, Exp 1/2022; 15573, Exp 7/2022; b) 12250, Exp 10/2020; 14589, 14848, Exp 12/2021; 15039, Exp 1/2022; 15245, Exp 2/2022; c) 12241, 12249, Exp 10/2020; 14222, Exp 8/2021; 15039, Exp 1/2022; 15037, 15246, Exp 2/2022; 15340, Exp 3/2022; 15387, Exp 4/2022"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0308-2019", "product_description": "Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/12.5 mg, (a) 30-count bottles (NDC 0093-7810-56) & 90-count bottles (NDC 0093-7810-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "19,458 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "NDC 0093-7810-56 & NDC 0093-7810-98  Lot # 20X006"}, {"status": "Completed", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ASPIRIN"], "generic_name": ["ASPIRIN 81 MG"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-434"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ASPIRIN"], "rxcui": ["318272"], "spl_id": ["29b6680a-7a7a-4b2d-e063-6394a90a7ff6"], "spl_set_id": ["56279fd2-bec3-4d77-86dd-2a3bd46c6109"], "package_ndc": ["63739-434-01", "63739-434-02"], "original_packager_product_ndc": ["69168-288"], "nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "unii": ["R16CO5Y76E"]}, "product_type": "Drugs", "event_id": "76631", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0513-2017", "product_description": "Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01.", "product_quantity": "6,717 cartons", "reason_for_recall": "Presence of Foreign Substance: foreign material found in the bulk inventory.", "recall_initiation_date": "20170223", "center_classification_date": "20170307", "report_date": "20170315", "code_info": "Lot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18"}, {"status": "Ongoing", "city": "Thornton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91084", "recalling_firm": "Adam's Polishes LLC", "address_1": "8225 N Valley Hwy", "address_2": "N/A", "postal_code": "80221-4810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0067-2023", "product_description": "Adam's Polishes ALCOHOL BASED HAND SANITIZER, isopropyl alcohol 75% v/v, packaged in a) 4 fl. oz (118) spray bottle, NDC 74943-125-04; b) 8 fl. oz (237 mL) spray bottle, NDC 74943-125-08; c) 1 PINT / 16 fl. oz (475 ml.) spray bottle, NDC 74943-125-16; and d) 1 GALLON / 128 fl. oz. (3,785 ml.) jug, NDC 74943-125-28, Manufactured by B&B Blending, LLC, Northglenn, CO.", "product_quantity": "3,441 gallons total", "reason_for_recall": "CGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.", "recall_initiation_date": "20221105", "center_classification_date": "20221122", "report_date": "20221123", "code_info": "Lots: 133470, 133471, 133472, 133473, 133474, 133476, 133477, 133478, 133479, 133480, 133481, 133482, 133483, 137731, 137732, 137733, 137734, 139322, 143327"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0889-2019", "product_description": "Dr. King's SafeCare Rx Poison Ivy & Oak Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955011620, NDC 57955-0116-2", "product_quantity": "441 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 091015L Exp. 09/18; 092216F Exp. 09/19"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "L5203 Exp 11/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Vitamin B12 Cyanocobalamin 5000 mcg Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-792-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0104-2020", "product_description": "SUCCinylcholine Chloride (PF), 140 mg/7 mL (20 mg/mL), 7 mL Fill in a 12 mL Single Dose Syringe, For IV Use Injection, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678417", "product_quantity": "1350 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-080-2013", "product_description": "Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "1,924,174 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HB27811"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0004-2024", "product_description": "lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1", "product_quantity": "1,992 5 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275788, Exp. 10/10/2023; 17-275872, Exp. 10/11/2023; 17-275922, Exp. 10/12/2023; 17-275972, 17-275973, Exp. 10/15/2023."}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1165-2023", "product_description": "TRP Natural Eyes, Stye Relief, Sterile Eye Ointment, Homeopathic 0.14 oz (4 grams), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-014-13.", "product_quantity": "180,315 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot:182002 EXP: 11/24; Lot:182003 EXP: 11/24; Lot:182004 EXP: 12/24; Lot:182005 EXP:02/25; Lot:182006 EXP:02/25; Lot:182007EXP:02/25; Lot:182008 EXP:02/25; Lot:182009 EXP:02/25; Lot:182010 EXP:03/25: Lot:182011 EXP:03/25;", "more_code_info": ""}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1099-2016", "product_description": "All naltrexone Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C243 BUD: 11/21/2018; D010 BUD: 1/11/2019; D025 BUD: 1/30/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 87.5mg pellet, 1 count (NDC 69761-187-01), 6 count (NDC 69761-187-06), 12 count (NDC 69761-187-12), and 30 count (NDC 69761-187-30) vials, Rx Only Qualgen,  LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0237-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA209179"], "brand_name": ["CHILDRENS IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Chalkboard Health"], "product_ndc": ["79395-003"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["9808ec56-25ae-44d6-9253-4498450020a2"], "spl_set_id": ["c63eb5c6-adac-4d23-9661-1081ba4591ba"], "package_ndc": ["79395-003-92"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "86567", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0065-2021", "product_description": "Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever Reducer, 4 fl oz (120 mL), Berry Flavor, Distributed by Chalkboard Health Inc. Princeton, NJ 08540 getfluenthealth.com Made in India. NDC 79395-003-92", "product_quantity": "7440 bottles", "reason_for_recall": "Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension  is missing dosing cups.", "recall_initiation_date": "20201022", "center_classification_date": "20201105", "termination_date": "20230404", "report_date": "20201111", "code_info": "Lot # BO1020080AA3, EXP 7/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-681-2015", "product_description": "Flunarizine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "10 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68532", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "37497 Schoolcraft Rd", "address_2": "N/A", "postal_code": "48150-1007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan and Wisconsin", "recall_number": "D-1559-2014", "product_description": "PEDIATRIC CARDIOPLEGIA, 255 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150", "product_quantity": "1 dose", "reason_for_recall": "Non Sterility; microbial contamination identified as Aspergillus species", "recall_initiation_date": "20140528", "center_classification_date": "20140825", "termination_date": "20140919", "report_date": "20140903", "code_info": "Lot # 13-920741-0-1 EXP 21 JUN 2014"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0046-2020", "product_description": "ePHEDrine Sulfate in 0.9% Sodium Chloride (PF), 50 mg/5 mL (10 mg/mL) 5 mL Fill in a 6 mL Syringe, Single Dose Syringe.  KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678375", "product_quantity": "3895 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1560-2019", "product_description": "DIPPIN' DOTS SCENTED BANANA SPLIT ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "13,068", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181210, Exp 12/09/2020"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0601-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Paralixer, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955501626, NDC 57955-5016-2", "product_quantity": "718 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 010118Z Exp. 01/20; 012616D Exp. 01/2019; 021717B Exp. 0919; 091216E Exp. 09/2019"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71013", "recalling_firm": "Reckitt Benckiser LLC", "address_1": "399 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1133", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1366-2015", "product_description": "Mucinex Fast Max Day Time Severe Cold and Fast-Max Night Time Cold & Flu  Two - 6 fl oz (180 mL) bottles Total -12 fl oz (360 mL), For Age 12+, Dist. By: Reckitt Benckiser Parsippany, NJ 07054-0224  Made in India, NDC 63824-526-22", "product_quantity": "561,390 Bottles", "reason_for_recall": "Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.", "recall_initiation_date": "20150415", "center_classification_date": "20150825", "termination_date": "20180309", "report_date": "20150902", "code_info": "WO00726864 6/30/2016  WO00737979 1/31/2017  WO00740405 1/31/2017  WO00706571 7/31/2016  WO00707442 7/31/2016  WO00707443 7/31/2016  WO00707444 7/31/2016  WO00707822 7/31/2016  WO00709953 7/31/2016  WO00709955 6/30/2016  WO00720780 7/31/2016  WO00721052 7/31/2016  WO00721170 7/31/2016  WO00721171 7/31/2016  WO00726865                 7/31/2016  WO00728864                 7/31/2016  WO00728865                 12/31/2016  WO00728866                 12/31/2016  WO00730003                 12/31/2016  WO00730004                 12/31/2016  WO00735142                 12/31/2016  WO00736753                 12/31/2016  WO00737477                 1/31/2017  WO00738556                 12/31/2016  WO00739050                 12/31/2016  WO00740406                 1/31/2017"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0650-2023", "product_description": "Cardioplegia Solution, Reperfusate No Potassium, packaged in 238.75 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0005-1.", "product_quantity": "255 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893790, Exp 04/28/2023; 37-896488, Exp 05/07/2023; 37-898250, Exp 05/14/2023; 37-899235, Exp 05/19/2023; 37-900609, Exp 05/25/2023"}, {"country": "United States", "city": "Los Angeles", "address_1": "450 N Van Ness Ave Apt 107", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.", "address_2": "", "product_quantity": "315 capsules", "code_info": "UPC # 891656002209, exp date 12/31/2021", "center_classification_date": "20180411", "distribution_pattern": "Product was distributed online via eBay.", "state": "CA", "product_description": "Red Zone Xtreme 3000 Capsules, Dietary Supplement Product, 1 count blister pack, UPC 8 91656 00200 9, Exp Date 12/31/2021", "report_date": "20180404", "classification": "Class I", "openfda": {}, "recalling_firm": "Jimmy Weber", "recall_number": "D-0625-2018", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "79476", "termination_date": "20190726", "more_code_info": "", "recall_initiation_date": "20180308", "postal_code": "90004-1577", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1184-2020", "product_description": "Testosterone w/ Atrevis 100 mg/mL GEL, 90 gm pump, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "3 bottles", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45114 Discard by: 08/20/2020; 45139 Discard by: 8/27/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Santa Clarita", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80184", "recalling_firm": "Shadow Holdings DBA Bocchi Labs", "address_1": "26421 Ruether Ave", "address_2": "N/A", "postal_code": "91350-2621", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0860-2018", "product_description": "Acne Shave (salicylic acid) Shave Cream Acne Shield, 0.5%, 5.1 FL OZ (150 mL) tube, Distributed by: United Exchange Corp., 17311 Valley View Blvd, Cerritos, CA 90703 USA, UPC 7 80707 73111 6.", "product_quantity": "8,208 tubes", "reason_for_recall": "CGMP Deviations: products may be contaminated with bacteria.", "recall_initiation_date": "20180525", "center_classification_date": "20180612", "termination_date": "20190813", "report_date": "20180620", "code_info": "All lots"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1165-2020", "product_description": "Sweat Oil, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0045-2019", "product_description": "Premier Value, Nasal Decongestant, No Drip Nasal Spray (oxymetazoline HCl) Nasal Solution, 12 Hour Pump Mist, Maximum Strength, 1 FL OZ (30 mL) bottle, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431, NDC 68016-308-03, UPC 8 40986 01519 9.", "product_quantity": "9024 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66913", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "recall_number": "D-1272-2014", "product_description": "15% Amino Acids Injection PBP Glass, 1000 mL, Catalog No. S3200-SS, Pharmacy Bulk Package, Not For Direct Infusion, For Intravenous Use, Sterile, Single Dose Container, Rx Only, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-3200-55", "product_quantity": "18,288 units", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "recall_initiation_date": "20131121", "center_classification_date": "20140425", "termination_date": "20141204", "report_date": "20140507", "code_info": "Lot# J2J012, Exp 01/14; J3B002, Exp 08/14", "more_code_info": ""}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["MAXIMUM STRENGTH HYDROCORTISONE CREAM WITH ALOE"], "generic_name": ["HYDROCORTISONE CREAM"], "manufacturer_name": ["Walgreens"], "product_ndc": ["0363-0620"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["39db4f23-5acc-04d7-e063-6294a90a7ef3"], "spl_set_id": ["61b93226-10ff-43df-b1b6-bcea917a2f48"], "package_ndc": ["0363-0620-02", "0363-0620-04"], "is_original_packager": [true], "upc": ["0311917179346", "311917179346"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"]}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1732-2019", "product_description": "Hydrocortisone Cream With Aloe, Hydrocortisone 1% / Anti-Itch Cream with Aloe, 2 OZ (56 g) tube. Distributed By: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC #0363-0620-04,  UPC 3 11917 17934 6", "product_quantity": "1223 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot #'s 11P17, 20P17 EXP 11/2019"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0274-2021", "product_description": "Epoprostenol Sodium for Injection, 0.5 mg/vial (500,000 ng),  1X10ML vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-1985-01.", "product_quantity": "12,629 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327537B, exp. date 09/2021"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029934 Exp. 11/19/2019,    10029820 Exp. 11/18/2019,    10029872 Exp. 11/19/2019,    10029873 Exp. 11/19/2019,    10030868 Exp. 11/28/2019,    10030567 Exp. 11/28/2019,      10030892 Exp. 12/2/2019,  10030567 Exp. 11/28/2019,    10030568 Exp. 11/28/2019,    10030892 Exp. 12/2/2019,    10031210 Exp. 12/9/2019,    10031211 Exp. 12/9/2019,    10031209 Exp. 12/12/2019,  10031439 Exp. 12/15/2019,    10031700 Exp. 12/22/2019,    10031438 Exp. 12/15/2019,    10031766 Exp. 12/26/2019,    10032225 Exp.12/29/2019,    10032260 Exp. 12/30/2019,    10032343 Exp. 12/31/2019,", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL in 35 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1099-49", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0551-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA022325"], "brand_name": ["NEXTERONE"], "generic_name": ["AMIODARONE HYDROCHLORIDE"], "manufacturer_name": ["Baxter Healthcare Company"], "product_ndc": ["43066-150", "43066-360"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMIODARONE HYDROCHLORIDE"], "rxcui": ["849876", "1046406", "1046408", "1046410"], "spl_id": ["aff0eecb-d97f-44bd-b149-5115dcacec53"], "spl_set_id": ["e9108958-b8d7-4fba-87c3-9a32990de551"], "package_ndc": ["43066-150-10", "43066-360-20"], "is_original_packager": [true], "unii": ["976728SY6Z"]}, "product_type": "Drugs", "event_id": "78531", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA and Puerto Rico", "recall_number": "D-0573-2018", "product_description": "Nexterone (amiodarone HCl) Premixed Injection, 150mg/100mL, 100-mL bag,  Rx Only, Sterile, Baxter Healthcare Corporation, Deerfield, IL. NDC 43066-150-10", "product_quantity": "35,628 single-dose containers", "reason_for_recall": "Presence of Particulate Matter:Particulate identified as polyethylene, the primary constituent of the film and ports used to manufacture the bag in which product is packaged", "recall_initiation_date": "20171110", "center_classification_date": "20180301", "termination_date": "20180829", "report_date": "20180207", "code_info": "Lot #, Expiry: NC109925, Exp 6/1/2019; NC109123, 5/2019", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89864", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0760-2022", "product_description": "quinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany,  NDC 59762-0223-1", "product_quantity": "1104 bottles", "reason_for_recall": "CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.", "recall_initiation_date": "20220321", "center_classification_date": "20220406", "termination_date": "20240828", "report_date": "20220413", "code_info": "Lot DP3414; Exp 02/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82941", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1333-2019", "product_description": "Sermorelin/GHRP-2 & 6 (3-3-3 MG) vials, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846", "product_quantity": "100 vials", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20190523", "center_classification_date": "20190607", "termination_date": "20210205", "report_date": "20190619", "code_info": "Lot #: 12062018:17 Exp. 06/04/2019"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207687"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-044", "16729-045", "16729-046", "16729-047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["40828d2e-69eb-5d38-e063-6394a90abd70"], "spl_set_id": ["4e06b20d-cc5d-46eb-991b-5972248de3af"], "package_ndc": ["16729-045-10", "16729-045-15", "16729-045-01", "16729-045-16", "16729-045-17", "16729-044-10", "16729-044-15", "16729-044-01", "16729-044-16", "16729-044-17", "16729-046-10", "16729-046-15", "16729-046-01", "16729-046-16", "16729-046-17", "16729-047-10", "16729-047-15", "16729-047-01", "16729-047-16", "16729-047-17"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"], "upc": ["316729045155", "316729045179"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0372-2023", "product_description": "Atorvastatin Calcium Tablets USP 20 mg* Rx Only, Packaged as  a) 90 Tablets NDC 16729-045-15 UPC 3 16729 04515 5; b) 1,000 Tablets NDC 16729-045-17 UPC 3 16729 04517 9, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "241,585 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a)R2100305, Exp. Date 2/28/2023; R2200227, Exp. Date 1/31/2024; R2200797, Exp. Date 6/30/2024;  b) R2101423, R2101438, R2101447, R2101446, Exp. Date 10/31/2023; R2200040, R2200041, R2200052, R2200043, R2200044, R2200051, R2200060, R2200061, R2200062, R2200077, R2200078, Exp. Date 12/31/2023; R2200228, R2200480, Exp. Date 1/31/2024; R2200266, R2200267, R2200265, R2200268, Exp. Date 2/29/2024; R2200370, Exp. Date 3/31/2024; R2201038, Exp. Date 6/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64154", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-137-2013", "product_description": "Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3.", "product_quantity": "11,580 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.", "recall_initiation_date": "20130116", "center_classification_date": "20130128", "termination_date": "20131205", "report_date": "20130206", "code_info": "Lot #: ZCMH12031, ZCMH12032, ZCMH12033, ZCMH12034, Exp 02/14", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "20", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Fentanyl Citrate 25 mcg/mL in 0.9% Sodium Chloride 25 mL in 30 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0521-67", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1286-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lexington", "address_1": "65 Hayden Avenue", "reason_for_recall": "Presence of Particulate Matter; Glass particulates observed in vials", "address_2": "", "product_quantity": "179,870 vials", "code_info": "Lot Numbers:   Lot 950453F, Exp. 12/06/2013   Lot 090203F, Exp. 09/07/2014   Lot 201703F, Exp. 08/31/2015   Lot 201653F, Exp. 09/01/2015", "center_classification_date": "20140117", "distribution_pattern": "Nationwide", "state": "MA", "product_description": "Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA", "report_date": "20140129", "classification": "Class I", "openfda": {}, "recalling_firm": "Cubist Pharmaceuticals, Inc.", "recall_number": "D-764-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66041", "termination_date": "20150210", "more_code_info": "", "recall_initiation_date": "20130829", "postal_code": "02421-7994", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-917-2015", "product_description": "Telaprevir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Brentwood", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPIPEN"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-500", "49502-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "727347", "727386", "1870207"], "spl_id": ["81569d26-e9b3-4c1d-ac34-8a4cf5b4a98b"], "spl_set_id": ["7560c201-9246-487c-a13b-6295db04274a"], "package_ndc": ["49502-500-01", "49502-500-02", "49502-500-92", "49502-501-01", "49502-501-02", "49502-501-92"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "76789", "recalling_firm": "Meridian Medical Technologies a Pfizer Company", "address_1": "2555 Hermelin Dr", "address_2": "", "postal_code": "63144-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand,  United Kingdom.  There has been no U.S. government or military distribution.", "recall_number": "D-0691-2017", "product_description": "EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS:  Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.", "product_quantity": "92,544 2-pak (U.S.); 198,579 syringes (O.U.S.)", "reason_for_recall": "Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication", "recall_initiation_date": "20170312", "center_classification_date": "20170428", "report_date": "20170510", "code_info": "US  lot 5GN767, expiration April 2017;  lot 5GN773, expiration April 2017;  lot 6GN215, expiration Sep 2017:    INTERNATIONAL  lot 5GR765, expiration March 2017;  lot 5GK771, expiration April 2017;  lot 5ED824, expiration April 2017; and   lot 6ED117, expiration ***", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0570-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Anti-Aging & Wrinkles for Women, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955814825, NDC 57955-8148-2", "product_quantity": "7783 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 010518L Exp. 01/20; 020718A Exp. 02/20; 050216R Exp. 05/19; 081815H Exp. 08/18; 101116C Exp. 10/19"}, {"status": "Terminated", "city": "Doral", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90675", "recalling_firm": "Distributor RFR, LLC.", "address_1": "3580 Nw 85th Ct Apt 150", "address_2": "N/A", "postal_code": "33122-1986", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Retail stores in the state of FL, Nationwide in the USA, France and Canada via website sales, and Bolivarian Republic of Venezuela", "recall_number": "D-1333-2022", "product_description": "SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285", "product_quantity": "2000 cartons", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.", "recall_initiation_date": "20220722", "center_classification_date": "20220809", "termination_date": "20250729", "report_date": "20220810", "code_info": "Lot: 48656, Exp. 01/2025"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71844", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1828-2015", "product_description": "PHENYLephrine HCl, 10 mg added to 250 mL 0.9% Sodium Chloride Injection USP (40 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX  77478, NDC# 61553-149-50", "product_quantity": "120 bags", "reason_for_recall": "Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).", "recall_initiation_date": "20150128", "center_classification_date": "20150923", "termination_date": "20170127", "report_date": "20150930", "code_info": "Lot #:  14308086S, Exp 02/02/15; 14309051S, Exp 02/03/15"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7800", "0264-7802"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807633", "1807634", "1807639"], "spl_id": ["9fa9f6b4-63b5-4632-8104-37c3dd1ee8fa"], "spl_set_id": ["7f22c06b-6b4d-4b49-a4b2-d2169f2bd653"], "package_ndc": ["0264-7800-00", "0264-7800-10", "0264-7800-20", "0264-7802-00", "0264-7802-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "89665", "recalling_firm": "B. Braun Medical, Inc.", "address_1": "901 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "USA Nationwide", "recall_number": "D-0655-2022", "product_description": "0.9% Sodium Chloride Injection USP, 250 mL Excel Container, Rx only, B. Braun Medical Inc., Bethlehem, PA, NDC 0264-7800-20", "product_quantity": "33,742 bags", "reason_for_recall": "Lack of sterility assurance: leaking bags", "recall_initiation_date": "20220225", "center_classification_date": "20220317", "termination_date": "20230316", "report_date": "20220323", "code_info": "Lot #: J1E086, J1E204, J1E213, Exp 5/31/2023; J1H137, J1H138, Exp 6/30/2023"}]